Voya Investment Management LLC Revance Therapeutics, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 34,158 shares of RVNC stock, worth $87,786. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,158

Previous 35,384 3.46%

Holding current value

$87,786

Previous $90,000 3.33%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.57 - $2.57 $3,150 - $3,150	-1,226 Reduced 3.46%	34,158 $87,000
Q2 2024 Dec 03, 2024	BUY	$2.34 - $4.73 $2,868 - $5,798	1,226 Added 3.59%	35,384 $90,000
Q2 2024 Aug 14, 2024	BUY	$2.34 - $4.73 $15,486 - $31,303	6,618 Added 23.01%	35,384 $90,000
Q1 2024 Dec 06, 2024	SELL	$4.65 - $9.31 $25,072 - $50,199	-5,392 Reduced 15.79%	28,766 $141,000
Q1 2024 May 15, 2024	SELL	$4.65 - $9.31 $25,272 - $50,599	-5,435 Reduced 15.89%	28,766 $141,000
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $3,968 - $7,649	683 Added 2.04%	34,201 $300,000
Q3 2023 Nov 14, 2023	BUY	$11.47 - $25.07 $4,507 - $9,852	393 Added 1.19%	33,518 $384,000
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $64,294 - $97,898	2,603 Added 8.53%	33,125 $838,000
Q4 2022 Feb 14, 2023	BUY	$18.32 - $30.66 $50,838 - $85,081	2,775 Added 10.0%	30,522 $563,000
Q3 2022 Mar 03, 2023	SELL	$14.33 - $28.47 $39,765 - $79,004	-2,775 Reduced 9.09%	27,747 $749,000
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $8,497 - $16,882	593 Added 2.18%	27,747 $749,000
Q2 2022 Aug 15, 2022	SELL	$11.52 - $20.4 $6,808 - $12,056	-591 Reduced 2.13%	27,154 $375,000
Q4 2021 Feb 14, 2022	BUY	$12.46 - $27.87 $4,074 - $9,113	327 Added 1.19%	27,745 $453,000
Q2 2021 Aug 16, 2021	SELL	$26.8 - $31.84 $7,262 - $8,628	-271 Reduced 0.98%	27,418 $813,000
Q1 2021 May 17, 2021	BUY	$24.03 - $29.97 $1,441 - $1,798	60 Added 0.22%	27,689 $774,000
Q4 2020 Feb 16, 2021	BUY	$23.41 - $28.34 $154,950 - $187,582	6,619 Added 31.5%	27,629 $783,000
Q3 2020 Nov 16, 2020	BUY	$23.23 - $34.3 $21,975 - $32,447	946 Added 4.71%	21,010 $528,000
Q2 2020 Aug 14, 2020	SELL	$12.6 - $26.55 $63,340 - $133,466	-5,027 Reduced 20.04%	20,064 $490,000
Q1 2020 May 15, 2020	BUY	$12.46 - $27.81 $40,532 - $90,465	3,253 Added 14.9%	25,091 $371,000
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $62,147 - $107,399	5,330 Added 32.29%	21,838 $354,000
Q3 2019 Nov 14, 2019	BUY	$10.22 - $14.5 $7,491 - $10,628	733 Added 4.65%	16,508 $215,000
Q2 2019 Aug 14, 2019	BUY	$10.67 - $15.49 $23,143 - $33,597	2,169 Added 15.94%	15,775 $205,000
Q4 2018 Feb 14, 2019	BUY	$18.06 - $24.96 $21,184 - $29,278	1,173 Added 9.43%	13,606 $274,000
Q2 2018 Aug 14, 2018	BUY	$27.45 - $33.35 $56,025 - $68,067	2,041 Added 19.64%	12,433 $341,000
Q3 2017 Nov 14, 2017	BUY	$22.55 - $28.1 $234,339 - $292,015	10,392	10,392 $286,000

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Revance Therapeutics, Inc. Transaction History